61. An advanced practice registered nurse (APRN) is providing education to a group of parents with college-bound high school seniors. The APRN mentions a vaccine that is highly recommended for students who will be living on campus. Which vaccine should be recommended?
Answer: B
Meningococcal B vaccine should be recommended for students living on campus.
Meningococcal B is a highly recommended vaccine for college students who will be living on campus due to the increased risk of meningococcal disease in communal living situations.
A) Pneumococcal vaccine
The pneumococcal vaccine is recommended for certain populations, primarily those at higher risk for pneumonia and other pneumococcal diseases. However, it is not specifically targeted at college students living on campus, making it less relevant in this context.
B) Meningococcal B
Meningococcal B is specifically indicated for college students, particularly those residing in dormitories or communal living settings, where the risk of transmission is higher. This vaccine protects against a serious bacterial infection that can lead to meningitis, which is why it is highly recommended for this demographic.
C) Hepatitis B
Hepatitis B vaccination is important for various populations, especially those at risk of exposure to the virus. However, it is not specifically indicated for college students living on campus and does not present the same immediate risk as meningococcal disease.
D) Human papillomavirus
The HPV vaccine is significant for preventing certain types of cancers and sexually transmitted infections. Nevertheless, it is not directly related to the risks associated with living on campus, unlike the meningococcal B vaccine, making it less appropriate for this particular recommendation.
Conclusion
Meningococcal B vaccine is the most pertinent recommendation for college-bound high school seniors due to the high risk of meningococcal disease in campus living situations. Other options, while important for public health, do not address the specific risks associated with communal living environments as effectively as the meningococcal B vaccine does.